Products

CHLOE BLAST
Fairtility
OB/GYN AI

See all 1 product →

About Fairtility

Fairtility is a healthcare AI company dedicated to revolutionizing In Vitro Fertilization (IVF) outcomes through transparent artificial intelligence. Their flagship product, CHLOE (Cultivating Human Life through Optimal Embryos), is an AI-based decision support tool designed to provide clinicians with comprehensive visibility into clinical and laboratory parameters. This technology aims to enhance IVF success rates, improve operational efficiency in the lab, and offer greater transparency to patients throughout their fertility journey.

For physicians, Fairtility’s CHLOE suite offers tools like CHLOE EQ (Embryo Quality Assessment Assistant), CHLOE KPI, and CHLOE OQ, which aim to span the entire IVF process, from assessing infertility causes to optimizing embryo transfer. By leveraging computer vision algorithms and analyzing millions of data points, including patient and embryo data, CHLOE provides objective and standardized embryo assessments. This can help embryologists work more efficiently, potentially reducing the time spent on administrative tasks by 33% and speeding up the clinical workflow. The system is designed to augment the expertise and intuition of IVF professionals, facilitating more informed decision-making and patient discussions, ultimately striving to reduce the number of IVF cycles needed for a live birth.

Focus Areas

In Vitro Fertilization (IVF) transparent AI embryo assessment oocyte assessment reproductive medicine digital healthcare medical decision support women's health

Business Intelligence

TechnologyCloud-based, AI operating system (CHLOE platform) utilizing computer vision algorithms and big data for embryo and oocyte assessment. Integrates with time-lapse incubators and EMR systems.

What Physicians Need to Know

Specialization: AI for IVF & Reproductive Care
Fairtility specializes in applying AI to various aspects of In Vitro Fertilization (IVF) and reproductive care, aiming to enhance clinical outcomes, optimize workflows, and improve the patient experience.
Core Product: CHLOE™ Platform
Their flagship product, CHLOE™ (Cultivating Human Life through Optimal Embryos), is an AI-powered decision support system for IVF professionals. It offers tools for embryo quality assessment (CHLOE EQ™ and CHLOE Blast™), oocyte assessment (CHLOE OQ™), lab performance tracking, and treatment insights.
Embryo Assessment
CHLOE™ analyzes embryo development using time-lapse imaging, capturing images every 10 minutes to create a detailed film of their full development. The AI assigns a score indicating the likelihood of a successful pregnancy and helps select the optimal embryo for transfer.
Oocyte Assessment
Fairtility also provides AI-generated reports, like VIOLET™, for assessing egg quality and predicting the likelihood of each egg developing into a blastocyst and achieving a successful pregnancy.
Clinical Decision Support
CHLOE™ acts as a transparent AI assistant, providing data-driven insights and analysis to assist fertility doctors and embryologists in making more informed decisions.
Workflow Optimization
The platform is designed to streamline clinic workflows, increase lab efficiency by up to 60%, and reduce manual administrative tasks, allowing embryologists to spend more time with patients.
Transparency in AI
Fairtility emphasizes 'Transparent AI,' meaning CHLOE™ reveals the clinical and lab parameters behind its recommendations, fostering trust among clinicians and providing patients with greater understanding.
Patient Empowerment
Through tools like the 'Embryo Development Viewer™' mobile app, patients can follow their embryo development, promoting greater involvement and transparency in their IVF journey.
FDA Clearance
Fairtility's CHLOE Blast™ has received FDA clearance for its AI-powered embryo assessment capabilities, setting a regulatory precedent in the field.
Physician Tip

For physicians, Fairtility's CHLOE™ platform offers a trustworthy AI companion that enhances clinical decision-making with objective, data-driven insights into embryo and oocyte viability, potentially reducing the number of IVF cycles needed for a successful live birth. Its transparent AI approach provides the 'why' behind the 'what,' explaining the biological events that lead to its conclusions, which can build greater trust and understanding. The system also optimizes lab workflows, freeing up embryologists from mundane administrative tasks and allowing them to focus more on patient care. Furthermore, the ability to offer patients real-time access to their embryo development through a mobile app can significantly improve patient engagement and satisfaction.

Fairtility's CHLOE™ platform adopts a vendor-neutral approach and seamlessly integrates with leading Electronic Medical Record (EMR) systems in reproductive care, including vRepro, IDEAS from Mellowood Medical, nAble IVF, and MedITEX. It also integrates with time-lapse incubator systems, automatically retrieving images and sending outputs via APIs into EMR systems, ensuring a digitized workflow and eliminating manual data entry. This creates a unified data and insights hub for fertility clinics, maximizing efficiency and standardizing data.

Products by Fairtility

1 product in the directory

CHLOE BLAST
Fairtility
OB/GYN AI

Videos

News, demos, and interviews about Fairtility.

Loading videos...

Videos load interactively. If none appear, search YouTube for Fairtility →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Fairtility's AI aims to standardize and optimize embryo and oocyte assessment in IVF by providing objective, data-driven insights. This can lead to more consistent evaluations, potentially improving success rates and reducing subjectivity in critical decision-making during fertility treatments.
Fairtility's AI is designed to integrate seamlessly into existing lab workflows, providing clinical decision support by offering real-time insights and predictions based on AI analysis of embryos and oocytes. This can help physicians and embryologists make more informed decisions, optimize treatment protocols, and enhance efficiency in fertility clinics.
Fairtility emphasizes transparency in its AI by providing explainable insights into its assessment criteria, allowing physicians to understand the rationale behind the AI's recommendations. This approach aims to build trust among healthcare professionals and facilitate clearer communication with patients regarding their treatment options and prognoses.
Fairtility offers a suite of AI-powered tools, such as CHLOE EQ, designed to assist with embryo evaluation and selection in IVF. These products aim to improve the chances of successful pregnancies for individuals and couples pursuing various family-building paths, including those undergoing IVF, egg freezing, and other fertility treatments.
Fairtility adheres to strict data privacy and security protocols, ensuring compliance with regulations such as HIPAA and GDPR to protect sensitive patient information. The company emphasizes anonymization and secure data handling practices to maintain confidentiality and trust within the healthcare ecosystem.
Fairtility typically offers a subscription-based pricing model for its AI solutions, which can vary based on the scale and specific needs of the clinic. They provide comprehensive support, including initial training, ongoing technical assistance, and clinical education to ensure seamless integration and effective utilization of their technology.
Fairtility aims to forge strategic partnerships with leading fertility clinics, research institutions, and technology providers to advance the field of reproductive medicine. The company demonstrates a strong growth trajectory, backed by significant investment and a commitment to continuous innovation in AI for fertility care.

Related Companies

Radin Health offers a comprehensive suite of AI-powered, cloud-based solutions designed to enhance operational efficiency across all stages of the radiology workflow. Their platform integrates a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-driven Dictation, and RADIN SELECT for workflow management. These solutions aim to improve efficiency and productivity for administrators, medical […]

Spectrum Dynamics Medical is a pioneering medical device company focused on transforming nuclear medicine from analog to digital technology. They specialize in developing high-definition, solid-state based nuclear imaging technology, including digital SPECT (Single Photon Emission Computed Tomography) and SPECT/CT systems. Their products aim to meet the clinical needs and workflow demands of diagnostic imaging departments […]

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Siemens Healthineers is a leading global medical technology company that pioneers breakthroughs in healthcare. The company focuses on medical technology and diagnostics, offering a wide range of products including imaging systems, laboratory diagnostics, and advanced therapies. Their innovations aim to improve patient outcomes and make healthcare more accessible and sustainable. Siemens Healthineers has a strong […]

Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.